Does CNS Prophylaxis Prevent CNS Relapse in Patients with High-Grade B-Cell Lymphoma Double-Hit and not Otherwise Specified?

被引:0
|
作者
Misyurina, Anna [1 ]
Kravchenko, Sergey [1 ]
Magomedova, Aminat [1 ]
Mangasarova, Yana [1 ]
Baryakh, Elena [2 ]
Misyurin, Vsevolod [3 ]
Kovrigina, Alla [1 ]
Obukhova, Tatyana [1 ]
Julhakyan, Hunan [1 ]
机构
[1] Natl Res Ctr Hematol, Moscow, Russia
[2] City Clin Hosp 52, Moscow, Russia
[3] Minist Hlth Russia, NN Blokhin Natl Med Canc Res Ctr, Moscow, Russia
来源
关键词
ABCL; aggressive B-cell lymphoma; CNS prophylaxis; high-grade B-cell lymphoma double-hit lymphoma;
D O I
10.1016/j.clml.2019.07.164
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ABCL-319
引用
收藏
页码:S254 / S255
页数:2
相关论文
共 50 条
  • [31] Diffuse Large B-Cell Lymphoma CNS Relapse Prophylaxis with Intrathecal or High-Dose Intravenous Methotrexate
    Zhou, Edward
    Zheng, Kelvin
    Phyu Thin Naing
    Boisclair, Stephanie
    Goldberg, Bradley
    BLOOD, 2023, 142
  • [32] Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
    Bobillo, Sabela
    Joffe, Erel
    Sermer, David
    Mondello, Patrizia
    Ghione, Paola
    Caron, Philip C.
    Hamilton, Audrey
    Hamlin, Paul A.
    Horwitz, Steven M.
    Kumar, Anita
    Matasar, Matthew J.
    Batlevi, Connie L.
    Moskowitz, Alison
    Noy, Ariela
    Owens, Collette N.
    Palomba, M. Lia
    Straus, David
    von Keudell, Gottfried
    Dogan, Ahmet
    Zelenetz, Andrew D.
    Seshan, Venkatraman E.
    Younes, Anas
    BLOOD CANCER JOURNAL, 2021, 11 (06)
  • [33] Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
    Sabela Bobillo
    Erel Joffe
    David Sermer
    Patrizia Mondello
    Paola Ghione
    Philip C. Caron
    Audrey Hamilton
    Paul A. Hamlin
    Steven M. Horwitz
    Anita Kumar
    Matthew J. Matasar
    Connie L. Batlevi
    Alison Moskowitz
    Ariela Noy
    Collette N. Owens
    M. Lia Palomba
    David Straus
    Gottfried von Keudell
    Ahmet Dogan
    Andrew D. Zelenetz
    Venkatraman E. Seshan
    Anas Younes
    Blood Cancer Journal, 11
  • [34] Prevention of CNS relapse in diffuse large B-cell lymphoma
    Kridel, Robert
    Dietrich, Pierre-Yves
    LANCET ONCOLOGY, 2011, 12 (13): : 1258 - 1266
  • [35] Favourable outcomes of double-hit/double-expressor lymphoma and high-grade B-cell lymphoma, not otherwise specified after early dose-intensive treatment and up-front autologous stem cell transplantation: a single-centre retrospective experience
    Struessmann, Tim
    Glatzki, Franziska
    Engelhardt, Monika
    Mertelsmann, Roland
    Duyster, Justus
    Finke, Juergen
    Marks, Reinhard
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (04) : 776 - 779
  • [36] Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse
    Samra, Bachar
    Khoury, Joseph D.
    Morita, Kiyomi
    Ravandi, Farhad
    Richard-Carpentier, Guillaume
    Short, Nicholas J.
    El Hussein, Siba
    Thompson, Philip
    Jain, Nitin
    Kantarjian, Hagop
    Jabbour, Elias
    BLOOD ADVANCES, 2021, 5 (20) : 3913 - 3918
  • [37] High-grade Double-hit Lymphoma in a 63-year-old Woman
    Eickelmann, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (11): : 864 - 864
  • [38] Primary CNS CCND1/MYC-Positive Double-Hit B-Cell Lymphoma: A Case Report and Review of the Literature
    Sakurai, Hiroko
    Sugimoto, Kei-Ji
    Shimada, Asami
    Imai, Hidenori
    Wakabayashi, Mutsumi
    Sekiguchi, Yasunobu
    Ota, Yasunori
    Izutsu, Koji
    Takeuchi, Kengo
    Komatsu, Norio
    Noguchi, Masaaki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (19) : E79 - E83
  • [39] Is There Still a Role for CNS Prophylaxis in Large B-Cell Lymphoma?
    Olszewski, Adam J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S43 - S44
  • [40] Establishment and characterization of a novel MYC/BCL2 double-hit high-grade B-cell lymphoma cell line HLA-3
    Guo, Hui
    Zhang, Hui
    Nomie, Krystle
    Zhang, Liang
    Murfin, Kelley P.
    Wang, Michael
    CANCER RESEARCH, 2019, 79 (13)